Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)
Clinical trial NCT04541043 · COMPLETED
Trial details
- NCT number
- NCT04541043
- Sponsor
- Calliditas Therapeutics AB
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2024-02-26
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.